Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 30, 2015
Pharmacy Choice - Pharmacy News - August 30, 2015

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
8/30/15 - Dr. Shawn Garber of New York Bariatric Group Executes Orbera Gastric Balloon Procedure for Non Surgical Weight Loss [Manufacturing Close - Up]
Shawn Garber has successfully implanted the first Orbera intragastric balloon in the Northeast since FDA approval. According to a release, although this procedure has had international success for over 20 years with dramatic weight loss results, the Orbera Gastric Balloon has only just been approved for use in the US by the FDA in the last several
8/29/15 - United States : LUPIN bags FDA approval to market Generic PrilosecCapsules [TendersInfo (India)]
Lupin Limited declared that it has obtained final approval from the United States Food and Drugs Administration to market its Omeprazole Delayed-Release capsules 40 mg, a generic version of AstraZeneca Pharmaceuticals LP Prilosec Delayed-Release capsules. Lupin stated that its Omeprazole Delayed-Release capsules are the AB rated generic equivalent.
8/28/15 - Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials [Global Data Point]
Mytrus was also the first electronic informed consent technology approved for use in a clinical trial by the U.S. Food and Drug Administration in 2011. It has since been used by some of the world's largest pharmaceutical companies in about 30 studies and received approvals from other national health authorities, as well as 50 institutional review b
8/28/15 - Sunovion Announces FDA Approval of a New Indication for Aptiom® (eslicarbazepine acetate) as Monotherapy for Partial-Onset Seizures
Sunovion Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration approved the supplemental New Drug Application for Aptiom ® as monotherapy for the treatment of partial-onset seizures. Previously approved in 2013 by the FDA as adjunctive therapy for partial-onset seizures, APTIOM is the only exclusively once-daily...
8/28/15 - US FDA approves new cholesterol lowering drug of Amgen [Big News Network (United Arab Emirates)]
WASHINGTON- American multinational biopharmaceutical company Amgen has received the US Food and Drug Administration approval for its new cholesterol-lowering medication, Repatha injection, becoming the second drug approved in a new class of drugs known as PCSK9 inhibitors. "We are excited about today's approval of Repatha in the US as patients and
8/28/15 - Veloxis Pharmaceuticals announces financial results for the first six months of 2015 and improves the full year outlook [Jerusalem Post (Israel)]
Veloxis Pharmaceuticals announces financial results for the first six months of 2015 and improves the full year outlook. On 10 July, 2015 Veloxis has received U.S. Food and Drug Administration approval of Envarsus ® XR for the prophylaxis of rejection in kidney transplant patients who require or desire conversion from other twice-daily tacrolimus.

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415